Editorial: an argument for low-dose thiopurine allopurinol combination use as first-line therapy in inflammatory bowel disease

被引：2
|
作者：
Ansari, A. R. [1 ]
Aziz, A. [1 ]
机构：
[1] Surrey & Sussex Healthcare NHS Trust, Dept Gastroenterol, Redhill, Surrey, England
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2018年 / 48卷 / 01期
关键词：
CO-THERAPY; HEPATOTOXICITY; AZATHIOPRINE;
D O I：
10.1111/apt.14687
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：97 / 98
页数：2
相关论文
共 50 条
  • [1] Editorial: an argument for low-dose thiopurine allopurinol combination use as first-line therapy in inflammatory bowel disease-authors' reply
    Friedman, A. B.
    Sparrow, M. P.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (01) : 98 - 99
  • [2] Low-dose thiopurine with allopurinol co-therapy overcomes thiopurine intolerance and allows thiopurine continuation in inflammatory bowel disease
    Vasudevan, Abhinav
    Beswick, Lauren
    Friedman, Antony B.
    Moltzen, Alicia
    Haridy, James
    Raghunath, Ajay
    Sparrow, Miles
    van Langenberg, Daniel
    [J]. DIGESTIVE AND LIVER DISEASE, 2018, 50 (07) : 682 - 688
  • [3] Safety and Efficacy of Split-Dose Thiopurine vs Low-Dose Thiopurine-Allopurinol Cotherapy in Pediatric Inflammatory Bowel Disease
    Cococcioni, Lucia
    Pensabene, Licia
    Puoti, Maria Giovanna
    El-Kouly, Sara
    Chadokufa, Sibongile
    Buckingham, Raechel
    Gaynor, Edward
    Saliakellis, Efstratios
    Kiparissi, Fevronia
    Borrelli, Osvaldo
    [J]. CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2023, 14 (03)
  • [4] IMPACT OF THIOPURINE DOSE IN COMBINATION THERAPY IN INFLAMMATORY BOWEL DISEASE
    Nawaz, Ahmad
    Glick, Laura
    Li, Darrick
    Gaidos, Jill
    Proctor, Deborah
    Al-Bawardy, Badr
    [J]. GASTROENTEROLOGY, 2022, 162 (03) : S107 - S108
  • [5] IMPACT OF THIOPURINE DOSE IN COMBINATION THERAPY IN INFLAMMATORY BOWEL DISEASE
    Nawaz, Ahmad
    Glick, Laura
    Li, Darrick
    Gaidos, Jill
    Proctor, Deborah
    Al-Bawardy, Badr
    [J]. INFLAMMATORY BOWEL DISEASES, 2022, 28 : S107 - S108
  • [6] Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases
    Elsa L. S. A. van Liere
    Ahmed B. Bayoumy
    Chris J. J. Mulder
    Ben Warner
    Bu Hayee
    Bilal A. Mateen
    Jonathan D. Nolan
    Nanne K. H. de Boer
    Simon H. C. Anderson
    Azhar R. Ansari
    [J]. Digestive Diseases and Sciences, 2022, 67 : 4008 - 4019
  • [7] Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases
    van Liere, Elsa L. S. A.
    Bayoumy, Ahmed B.
    Mulder, Chris J. J.
    Warner, Ben
    Hayee, Bu
    Mateen, Bilal A.
    Nolan, Jonathan D.
    de Boer, Nanne K. H.
    Anderson, Simon H. C.
    Ansari, Azhar R.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (08) : 4008 - 4019
  • [8] Allopurinol-thiopurine combination therapy in inflammatory bowel disease: are there genetic clues to this puzzle?
    Roberts, Rebecca L.
    Gearry, Richard B.
    Barclay, Murray L.
    [J]. PHARMACOGENOMICS, 2010, 11 (11) : 1505 - 1508
  • [9] Low-dose combination therapy: An important first-line treatment in the management of hypertension
    Neutel, JM
    Smith, DHG
    Weber, MA
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2001, 14 (03) : 286 - 292
  • [10] Low-dose combination therapy as first-line hypertension treatment for blacks and nonblacks
    Prisant, LM
    Neutel, JM
    Ferdinand, K
    Papademetriou, V
    DeQuattro, V
    Hall, WD
    Weir, MR
    [J]. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 1999, 91 (01) : 40 - 48
12345